RTA 301 (peloruside): a novel microtubule stabilizer with potent vivo activity against lung cancer and resistant breast cancer

被引：9
|
作者：
Meyer, C.
Ferguson, D.
Krauth, M.
Wick, M.
Northcote, P.
机构：
[1] Reata Pharmaceut Inc, Dallas, TX USA
[2] CTRC Inst Drug Dev, San Antonio, TX USA
[3] Univ Victoria, Wellington, New Zealand
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70644-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
639
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [31] A novel palladacycle complex with anticancer activity against breast cancer and melanomas also exhibits potent cytotoxicity in a range of sarcomas
    Bleloch, Jenna
    Ballim, Reyna
    Aliwaini, Saeb
    Blanckenberg, Angelique
    Mapolie, Selwyn
    Kimani, Serah
    Prince, Sharon
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 52 - 52
  • [32] Clomiphene analogs with activity in vitro and in vivo against human breast cancer cells
    Baumann, RJ
    Bush, TL
    Cross-Dorsen, DE
    Cashman, EA
    Wright, PS
    Zwolshen, JH
    Davis, GF
    Matthews, DP
    Bender, DM
    Bitonti, AJ
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (06) : 841 - 851
  • [33] Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo
    Xie, Baohua
    Yin, Zhinang
    Hu, Zhiye
    Lv, Junhui
    Du, Chuanqian
    Deng, Xiangping
    Huang, Yuan
    Li, Qiuzi
    Huang, Jian
    Liang, Kaiwei
    Zhou, Hai-Bing
    Dong, Chune
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (10) : 6631 - 6651
  • [34] Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer
    Utsugi, T
    Shibata, J
    Sugimoto, Y
    Aoyagi, K
    Wierzba, K
    Kobunai, T
    Terada, T
    OhHara, T
    Tsuruo, T
    Yamada, Y
    CANCER RESEARCH, 1996, 56 (12) : 2809 - 2814
  • [35] A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer
    Zimmermann, S
    Wels, W
    Froesch, BA
    Gerstmayer, B
    Stahel, RA
    ZangemeisterWittke, U
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (01) : 1 - 9
  • [36] A NOVEL ORAL ? AND ? TUBULIN INHIBITOR, VERU-111, HAS POTENT ACTIVITY AGAINST PACLITAXEL SENSITIVE AND RESISTANT PROSTATE CANCER
    Getzenberg, Robert
    Dalton, James
    Miller, Duane
    Steiner, Mitchell
    JOURNAL OF UROLOGY, 2018, 199 (04): : E694 - E694
  • [37] Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity
    Guzman, Esther A.
    Xu, Qunli
    Pitts, Tara P.
    Mitsuhashi, Kaoru Ogawa
    Baker, Cheryl
    Linley, Patricia A.
    Oestreicher, Judy
    Tendyke, Karen
    Winder, Priscilla L.
    Suh, Edward M.
    Wright, Amy E.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2116 - 2126
  • [38] A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer
    Sandra Zimmermann
    Winfried Wels
    Barbara A. Froesch
    Bernd Gerstmayer
    Rolf A. Stahel
    U. Zangemeister-Wittke
    Cancer Immunology, Immunotherapy, 1997, 44 : 1 - 9
  • [39] Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo
    Wang, Liang-Liang
    Kong, Lingmei
    Liu, Hui
    Zhang, Yunqin
    Zhang, Li
    Liu, Xingyong
    Yuan, Feng
    Li, Yan
    Zuo, Zhili
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 182
  • [40] Antitumor activity of a novel (-)-antofine analog in human lung cancer cells and paclitaxel-resistant lung cancer cells
    Song, Jayoung
    Bae, Song Yi
    Shin, Yoonho
    Kim, Won Kyung
    Oh, Jedo
    Choi, Tae Joon
    Jeong, Eun Ju
    Park, So Hyun
    Jang, Eun Jeong
    Kang, Ji In
    Park, Hyen Joo
    Hong, Ji-Young
    Chung, Hwa-Jin
    Kwon, Yongseok
    Kim, Sanghee
    Lee, Sang Kook
    CANCER RESEARCH, 2014, 74 (19)
12345